Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Cardiovascular disease is a competing cause of death in patients with cancer with early-
stage disease. This elevated cardiovascular disease risk is thought to derive from both the …

Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

Background In patients at risk of cancer therapy-related cardiac dysfunction (CTRCD),
initiation of cardioprotective therapy (CPT) is constrained by the low sensitivity of ejection …

Aims This observational study characterized cardiovascular disease (CVD) mortality risk for
multiple cancer sites, with respect to the following:(i) continuous calendar year,(ii) age at …

Background The past few decades have seen substantial improvements in cancer survival,
but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is …

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American
Society of Clinical Oncology Clinical P Page 1 City of Hope, Duarte, CA; American Society …

PURPOSE To examine cardiovascular disease (CVD) and mortality risk in women with
breast cancer (BC) by cancer therapy received relative to women without BC. METHODS …

Background: Cancer therapy–induced cardiomyopathy (CCM) is associated with cumulative
drug exposures and preexisting cardiovascular disorders. These parameters incompletely …

Background More than 80% of adult patients diagnosed with cancer survive long term. Long-
term complications of cancer and its therapies may increase the risk of cardiovascular …